tradingkey.logo

Natera Says To Present 14 Studies At ESMO, Including Imvigor011 Oral Presentation

ReutersOct 12, 2025 10:13 PM

- Natera Inc NTRA.O:

  • NATERA INC: NATERA TO PRESENT 14 STUDIES AT ESMO, INCLUDING IMVIGOR011 ORAL PRESENTATION

  • NATERA INC - SIX ORAL PRESENTATIONS HIGHLIGHT SIGNATERA'S ROLE IN SOLID TUMORS

  • NATERA: ADDITIONAL ORAL PRESENTATIONS INCLUDE RESULTS FROM SUNRISE-4 TRIAL , INTERCEPT TRIAL IN COLORECTAL CANCER, & NATERA'S EARLY CANCER DETECTION PROGRAM

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI